CL
58
-8
K
59
2
SWKS
39
2
CF
35
3
HPE
10
4
PG
61
-7
WBA
50
2
KMI
59
4
SYK
37
2
DNB
40
2
SIG
52
3
NRG
54
9
MMM
56
7
PX
42
2
AES
44
-3
EMC
53
11
COP
47
17
EBAY
42
2
GOOG
55
5
CI
63
-5
CL
58
-8
K
59
2
SWKS
39
2
CF
35
3
HPE
10
4
PG
61
-7
WBA
50
2
KMI
59
4
SYK
37
2
DNB
40
2
SIG
52
3
NRG
54
9
MMM
56
7
PX
42
2
AES
44
-3
EMC
53
11
COP
47
17
EBAY
42
2
GOOG
55
5
CI
63
-5
Financhill
Back

Ameriprise Financial Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
58

AMP
Ameriprise Financial

Last Price:
$474.16
Seasonality Move:
6.81%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.13
Seasonality Move:
6.73%
Buy
58
Ameriprise Financial (AMP) is a Buy

Is Ameriprise Financial a Buy, Sell or Hold?

  • The current Ameriprise Financial [AMP] share price is $480.46. The Score for AMP is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • AMP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AMP Stock Price Chart

What is Ameriprise Financial's stock price today?

  • The Ameriprise Financial share price today is $480.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMP is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

AMP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -13.89 Sell
Relative Strength Index (14 RSI): 30.34 Sell
Chaikin Money Flow: -58775 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (506.16 - 545.06) Sell
Bollinger Bands (100): (515.78 - 560.4) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

AMP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 504.66 Sell
20-day SMA: 522.46 Sell
50-day SMA: 534.46 Sell
200-day SMA: 487.71 Sell
8-day EMA: 499.95 Sell
20-day EMA: 516.94 Sell
50-day EMA: 528.79 Sell
200-day EMA: 493.81 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Ameriprise Financial Earnings Growth & AMP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.84 per share, an increase next quarter of $0.33 per share, an increase this year of $3.54 per share, and an increase next year of $3.71 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Ameriprise Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):